Historic Treatments and the Need for Menin Inhibitors

In this episode, Sanja Zepcan, PharmD, BCPS, BCOP, explores the limitations of salvage chemotherapy regimens in this patient population and introduces allogeneic stem cell transplant as the only curative option. She discusses why menin inhibitors represent a paradigm shift as a bridge to transplant and shares why pharmacists must understand transplant eligibility as a meaningful treatment end point, not a distant contingency.